Bacterial infection is one of the leading causes of death in young, elderly, and immune-compromised patients. The rapid spread of multi-drug-resistant (MDR) bacteria is a global health emergency and there is a lack of new drugs to control MDR pathogens. We describe a heretofore-unexplored discovery pathway for novel
antibiotics that is based on self-targeting, structure-disrupting
peptides. We show that a helical
peptide, KFF- EcH3, derived from the Escherichia coli
methionine aminopeptidase can disrupt secondary and tertiary structure of this essential
enzyme, thereby killing the bacterium (including MDR strains). Significantly, no detectable resistance developed against this
peptide. Based on a computational analysis, our study predicted that
peptide KFF- EcH3 has the strongest interaction with the structural core of the
methionine aminopeptidase. We further used our approach to identify
peptide KFF- NgH1 to target the same
enzyme from Neisseria gonorrhoeae. This
peptide inhibited bacterial growth and was able to treat a gonococcal
infection in a human cervical epithelial cell model. These findings present an exciting new paradigm in
antibiotic discovery using self-derived
peptides that can be developed to target the structures of any essential
bacterial proteins.-Zhan, J., Jia, H., Semchenko, E. A., Bian, Y., Zhou, A. M., Li, Z., Yang, Y., Wang, J., Sarkar, S., Totsika, M., Blanchard, H., Jen, F. E.-C., Ye, Q., Haselhorst, T., Jennings, M. P., Seib, K. L., Zhou, Y. Self-derived structure-disrupting
peptides targeting
methionine aminopeptidase in pathogenic bacteria: a new strategy to generate
antimicrobial peptides.